Researchers developed the seats to measure biometrics during ‘natural’ processes
With 1 million new cases of congestive heart failure diagnosed each year, a revolutionary product is making it easier for hospitals to monitor patients with the condition in the comfort of their own homes.
A toilet-seat based cardiovascular monitoring system created by a team of Rochester Institute of Technology researchers, aims to lower the hospital readmission rates of patients with congestive heart failure. The toilet seats, which will be brought through the FDA clearance process by the researchers’ company Heart Health Intelligence, would be purchased by hospitals and issued to heart failure patients after discharge. The toilet seats are equipped to measure the electrical and mechanical activity of the heart, and can monitor heart rate, blood pressure, blood oxygenation levels, and the patient’s weight and stroke volume, which is the amount of blood pumped out of the heart at every beat. Algorithms analyze the data, and with further development, will alert advanced practice providers of a deteriorating condition. A report will be passed along to cardiologists who will then determine if intervention is necessary.
Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that developed the toilet seats.
“Typically, within 30 days of hospital discharge, 25 percent of patients with congestive heart failure are readmitted,” said Conn. “After 90 days of hospital discharge, 45 percent of patients are readmitted. And the Centers for Medicare and Medicaid Services is penalizing hospitals for readmitting patients for heart failure.”
Conn, the company’s chief executive officer, further explains that using the national average for readmission rates, the penalty alone for readmitting 150 patients is approximately $500,000 annually. The total cost of providing 150 patients with their own monitored toilet seats from HHI is $200,000. With that investment, he says, hospital systems will save more than double their initial investment within one year.
According to Conn, who earned three degrees from RIT—a bachelor’s degree and a master’s degree in electrical engineering in 2011 and 2013, respectively, and a doctoral degree in microsystems engineering in 2016—the system will pick up deteriorating conditions before the patients even realize they are symptomatic. And with the rapid data analysis, interventions can be as simple as a drug change or short office visit, instead of an admission to the hospital.
HHI, which joined RIT’s Venture Creations business incubator earlier this year, is now focused on moving the product forward. The team is heavily involved in writing grants for additional funding and networking, and human-subject testing and pre-clinical studies are well underway. Conn and his team are working on approving the product with the FDA and rolling it out across the country.
Learn more: Toilet seat that detects congestive heart failure getting ready to begin commercialization
The Latest on: Congestive heart failure
[google_news title=”” keyword=”congestive heart failure” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Congestive heart failure
- What Are The Possible Complications Atrial Flutter? A Review By Doctorson May 8, 2024 at 1:09 am
Expert opinion from Mohan P. Abraham M.D., FAAFP (Family Physician) · 40 years of experience · USA The problem with atrial flatter is the fact that it stops your heart from pumping the blood well ...
- From heart failure to heart function: Jennifer’s storyon May 7, 2024 at 1:05 pm
Jennifer was a healthy 4-year-old when she was diagnosed with heart failure (cardiomyopathy). Learn more about heart failure risks, diagnosis & management ...
- ACLU files suit against federal government, claiming supervised release and parole rules set people with disabilities up for failureon May 7, 2024 at 9:31 am
When someone is released on parole or supervised release in D.C., there is a lot that person must do to stay out of prison.
- Will Study Linking Vapes With Heart Failure Survive Scrutiny?on May 6, 2024 at 7:46 am
The research has sparked headlines, but has yet to be published in a peer-reviewed journal. Some experts point to red flags.
- Gary Floyd, Scene-Defining Singer of Austin Punks the Dicks, Has Diedon May 3, 2024 at 3:24 am
He was taken off life support after a stay in the hospital with congestive heart failure. Floyd grew up in Palestine, Texas and spent two years in Houston – where Floyd, a conscientious objector, ...
- Could vaping one time put you at a higher risk of heart failure?on April 29, 2024 at 2:38 pm
Could vaping just one time put you at higher risk of heart failure? More research is pointing to the dangers of e-cigarettes.
- 'Mind Your Heart' study to enroll patients diagnosed with heart failureon April 26, 2024 at 10:31 am
Swollen legs, ankles and shortness of breath are just a few of the symptoms of congestive heart failure.
- First generic pimobendan chewable tablets for canine congestive heart failure receives FDA approvalon April 26, 2024 at 6:44 am
The drug from Cronus Pharma contains the same active ingredient as Boehringer Ingelheim's Vetmedin.
- Congestive heart failure: Stages and typeson April 24, 2024 at 5:00 pm
Systolic congestive heart failure is a serious condition that occurs when the heart does not pump blood effectively. There are four stages of congestive heart failure. Congestive heart failure may ...
- FDA fast tracks investigational gene therapy for heart failureon April 24, 2024 at 7:00 am
The US Food and Drug Administration (FDA) has granted Fast Track designation to invesigational gene therapy AB-1002 for treatment of congestive heart failure (CHF).AB-1002 is an ...
via Bing News